FDA Brief

Company record

Medolife Rx D/B/A MedoLife Corp., AELIA, Inc. and Quanta Inc.

1 FDA warning letter since 2023 and 0 recalls in the last 12 months.

Get an email the day FDA posts anything new about Medolife Rx D/B/A MedoLife Corp., AELIA, Inc. and Quanta Inc..

Warning letters

  1. Medolife Rx D/B/A MedoLife Corp., AELIA, Inc. and Quanta Inc.

    FDA says Medolife sold unapproved Escozine drugs online with claims to treat cancer, HIV, and COVID-19.

    High risk